in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Siegfried reports increase in profits and revenue, sees positive trend in second half
8:39 AM MDT | August 26, 2013 | Natasha Alperowicz
Siegfried (Zofingen, Switzerland), a producer of active pharmaceutical ingredients (APIs), pharma intermediates, and finished dosage form products, reports a significant rise in sales and profits in the first six months of 2013. Net profit was up 41%, at 18.5 million Swiss francs ($20.1 million), on sales 10% higher, at SF196.7 million. Ebitda was 31% higher, at SF27.9 million, corresponding to a margin of 14.2% compared with 11.9% achieved in the year-earlier period. Ebit rose 72%, to SF15.6 million. “Siegfried‘s considerable sales growth is a...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee